-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary
-
Medicine, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug
-
biochemistry, molecular biology, and cell biology methods with state-of-the-art technologies such as comprehensive mouse phenotyping, 3D tissue clearing & imaging, in vivo transplantation and 3D imaging
-
deciphering their underlying molecular mechanisms in normal developmental processes and tumorigenesis. We cover research areas with relevance to RNA Biology, Cancer Biology, Chromatin Regulation, Cancer
-
-high-throughput screening, and structural biophysics. We are looking for a postdoctoral scientist who will work at the crossover of chemistry, biology, and engineering to advance these technologies from
-
biomedical sciences, or a related discipline · Experience in tissue culture, cellular and molecular biology, and related methodologies · Experience of advanced multi-parameter flow cytometry
-
approaches is currently used in the lab. Following up with the new paradigm revealed about uridine metabolism by Drs. Deng and Scherer (Science, 2017), the Deng lab is currently focusing on three areas: 1
-
utilizes genetic mouse models, molecular biology, imaging and epigenetic techniques to study the cellular identity, function, remodeling, and survival of beta-cells in physiological and pathological
-
top journals such as Journal of Hematology & Oncology (2024), Cancer Research (2024), Cell (2023), Cell Stem Cell (2023 ×2), and Nature Cell Biology (2022). The Su research program is currently
-
and epigenetic regulations and deciphering their underlying molecular mechanisms in normal developmental processes and tumorigenesis. We cover research areas with relevance to RNA Biology, Cancer